Addiction PsychologyChild Welfare & ProtectionClinical AssessmentFamily Psychology

Parent/Care-Giver Drug Issues Checklist

The Parent/Care-Giver Drug Issues Checklist (DrugNet, 1997) is a structured professional judgment risk assessment tool designed to evaluate the impact of parental substance misuse on child safety, parenting capacity, and family functioning across seven ecological domains.

memjavad
PUBLISHED
Scientifically Reviewed · Dr. Marwa Abd-Alazim · September 16, 2026
Medically & Scientifically Reviewed Verified: September 16, 2026
Dr. Marwa Abd-Alazim Ph.D.
Professor of Psychology University of Kerbala
Review Criteria & Clinical Standards

This content undergoes rigorous scientific peer-review and medical editorial standards at Arab Psychology Network to ensure clinical accuracy, validity, and compliance with evidence-based guidelines from leading psychological and healthcare authorities (APA / WHO).

Abstract

The Parent/Care-Giver Drug Issues Checklist is a specialized clinical risk assessment instrument developed in 1997 by DrugNet (Professional Drug Management for Clinicians & Educators) to evaluate the systemic impact of parental substance misuse on child welfare, developmental safety, and family functioning. Designed primarily for social workers, child protection officers, clinical psychologists, addiction counselors, and community health nurses, the instrument operationalizes the multi-layered risks associated with adult chemical dependency within domestic environments. The checklist comprises seven core assessment domains: (1) The Pattern of Parental Drug Use, (2) Accommodation and Home Environment, (3) Provision of Basic Necessities, (4) Procurement of Drugs, (5) Health Risks, (6) Family’s Social Network and Support Systems, and (7) The Parents’ Perception of the Situation. Across these seven qualitative domains, the clinician explores 33 primary observational criteria and operational probes.

Departing from traditional linear additive scoring models, the instrument utilizes an actionable four-category ordinal triage metric: -1 denotes a verified protective factor (“Positive – congratulate”); 1 denotes an emergent vulnerability requiring structured monitoring (“Transitional – somewhat an issue”); 2 identifies an acute hazard demanding crisis safeguarding (“Problematic – requires immediate attention”); and “?” designates diagnostic ambiguity (“Unsure – further information required or N/A”). This psychometric architecture explicitly balances deficits against family resilience factors, mitigating confirmation bias in statutory evaluations. While early field implementations reported robust content validity and inter-rater agreement across multi-disciplinary child safeguarding teams (intraclass correlation coefficients frequently exceeding .80), empirical psychometric research emphasizes its status as a structured professional judgment (SPJ) tool rather than a norm-referenced psychometric test. This comprehensive profile outlines the instrument’s conceptual architecture, theoretical foundations in ecological systems and attachment theory, psychometric properties, clinical administration workflows, and research implications.

Keywords

Parent/Care-Giver Drug Issues Checklist, parental substance misuse, child protection risk assessment, structured professional judgment, family preservation, substance use disorders, child neglect, ecological systems theory, parental capacity to change, DrugNet 1997.

Authors

The Parent/Care-Giver Drug Issues Checklist was formulated and promulgated by DrugNet (Professional Drug Management for Clinicians & Educators) in 1997. DrugNet functioned as an early clinical knowledge exchange consortium and training network based in the United Kingdom and Australia, focused on disseminating evidence-informed protocols, psychoactive substance guidelines, harm reduction frameworks, and child protection risk assessment tools for frontline multidisciplinary professionals.

The development of the checklist reflected collaborative contributions from clinical nurse specialists in addiction medicine, child and family social workers, forensic child psychologists, and community health practitioners seeking a standardized, non-pejorative, yet rigorous ecological assessment aid. Inquiries regarding archival materials, historical training manuals, and permission guidelines are traditionally referenced through historical addiction practice clearinghouses and specialized literature in social welfare informatics.

Purpose

Parental substance misuse represents one of the most persistent and complicated challenges within family courts, statutory child protection systems, and clinical addiction treatment environments. Exposure to chronic parental chemical dependency places children at elevated risk for physical neglect, psychological trauma, environmental hazards, household instability, educational disruption, and developmental psychopathology. However, parental drug use in isolation does not uniformly correlate with maltreatment; parenting capacity exists along a dynamic continuum influenced by socio-environmental stressors, poly-substance dynamics, socioeconomic resources, psychiatric comorbidity, and relational protective buffers.

The primary purpose of the Parent/Care-Giver Drug Issues Checklist is to structure professional observation, eliminate idiosyncratic clinician bias, and systematically distinguish between parental substance consumption that does not directly impede child development and severe, chaotic substance use that actively imperils child physical, emotional, and cognitive safety. The instrument was deliberately formulated to fulfill several vital clinical, forensic, and social care objectives:

  • Structured Child Safeguarding Risk Triage: To provide statutory child welfare caseworkers, multidisciplinary assessment teams, and court-appointed guardians with a clear, standardized framework to evaluate immediate domestic dangers, such as unsecured drug paraphernalia, exposure to criminal networks, home abandonment, and nutritional or medical deprivation.
  • Holistic Ecological Profiling: To bypass reductionist models that measure only toxicology or frequency of parental drug ingestion, replacing them with a broad systemic appraisal of the child’s living environment, household economics, social capital, school attendance, and emotional containment.
  • Identification of Protective Factors and Strengths: By incorporating a deliberate counter-deficit scoring category (-1: “Positive – congratulate”), the checklist ensures clinicians identify functional parenting capacities, kin support, stable partnerships, and active engagement with harm reduction services, thereby facilitating tailored family preservation plans rather than reflexive child removal.
  • Monitoring Trajectory and Parental Capacity to Change: To serve as a repeated-measures tracking device across longitudinal addiction treatment episodes, enabling caseworkers to evaluate whether transitions from chaotic street drug procurement to stable opioid substitution therapy (OST) correlate with verifiable enhancements in home hygiene, school regularity, and affective responsiveness.
  • Forensic and Inter-Agency Communication: To establish a shared clinical vernacular among disparate professional groups—including adult addiction psychiatrists, community pediatricians, juvenile justice workers, and legal representatives—ensuring documented concerns are specific, operationalized, and actionable.

Psychological Construct

The underlying construct evaluated by the Parent/Care-Giver Drug Issues Checklist is Parental Capacity within the Context of Substance Misuse. This multi-dimensional construct captures the operational intersection between an adult’s drug-taking behaviors and their cognitive, psychological, and logistical ability to ensure the physical safety, emotional nurturance, environmental stability, and developmental socialization of dependent children. Rather than conceptualizing addiction as an all-or-nothing determinant of child maltreatment, the construct operationalizes risk and protection across seven distinct clinical dimensions:

1. The Pattern of Parental Drug Use

This dimension assesses the phenomenological nature of the parent’s substance involvement. It differentiates experimental and controlled recreational consumption from chaotic, poly-drug, or compulsive dependence. Key psychological indicators include whether the caregiver exhibits predictable periods of intoxication and withdrawal, whether parenting quality fluctuates between drug-using and sober intervals, the presence of a non-using protective adult, and co-occurring psychiatric conditions (dual diagnosis) that exacerbate parental unresponsiveness or affective dysregulation.

2. Accommodation and Home Environment

This subscale evaluates the physical, environmental, and interpersonal stability of the living quarters. The construct operationalizes housing security (e.g., consistency of rent and utility payments, frequency of evictions or transient moves), domestic safety (e.g., exposure to unvetted drug users sharing the residence, domestic violence, conflicts with dealers), and whether children witness substance ingestion or dangerous illicit subcultures within their home.

3. Provision of Basic Necessities

This domain captures the practical, day-to-day fulfillment of foundational child developmental needs. It examines material adequacy—such as clean clothing, nutritional intake, and environmental warmth—alongside developmental scaffolding, including consistent school attendance and age-appropriate play. Crucially, it measures parentification: the psychological role reversal whereby children assume adult domestic, emotional, or caretaking duties for impaired parents or younger siblings.

4. Procurement of Drugs

This dimension measures the operational behaviors required to finance and acquire illicit or non-prescribed substances. It assesses child endangerment directly linked to procurement pathways, including leaving young children unattended, transporting minors to dangerous transactional settings, diverting family income from essential sustenance to drug purchasing, and utilizing the family home for drug distribution or illicit congregations.

5. Health Risks

This dimension addresses the acute biophysical hazards generated by parental drug paraphernalia and administration practices. It evaluates the secure storage or hazardous exposure of syringes, pipes, adulterants, and opioid pharmacotherapies (such as methadone or buprenorphine). It also examines parental hygiene practices, needle exchange utilization, syringe disposal, awareness of pediatric poisoning dangers, and active engagement with specialized medical or harm reduction services.

6. Family’s Social Network and Support Systems

This subscale assesses the social capital, kinship networks, and external community integration surrounding the family unit. The construct explores whether the family is embedded in an insulated drug-using subculture versus a supportive pro-social network, the availability and willingness of extended relatives to provide respite care, and the family’s openness to statutory or voluntary community agency interventions, explicitly accounting for the compounding impact of rural isolation and social stigmatization.

7. The Parents’ Perception of the Situation

This critical psychological dimension evaluates the caregiver’s insight, cognitive appraisal, and readiness to change (in alignment with the Transtheoretical Model). It explores whether the parent acknowledges the adverse effects of their drug use on child development, whether they exhibit narcissistic or compulsive prioritization of chemical urges over child welfare, and their comprehension of child protection mandates and statutory legal responsibilities.

Theoretical Framework

The architectural foundation of the Parent/Care-Giver Drug Issues Checklist synthesizes three prominent theoretical frameworks in developmental psychology, clinical social work, and addiction medicine:

1. Bronfenbrenner’s Ecological Systems Theory

At its theoretical core, the checklist is organized around Urie Bronfenbrenner’s Ecological Systems Theory. Bronfenbrenner posited that human development is shaped by reciprocal interactions across nested environmental systems: the microsystem, mesosystem, exosystem, and macrosystem. The checklist operationalizes this ecological perspective directly:

  • Microsystem: Immediate caregiving dyads, parent-child affective exchanges, emotional containment, physical warmth, and home hygiene (covered in Provision of Basic Necessities and The Pattern of Parental Drug Use).
  • Mesosystem: Connections between the family home and external developmental settings, such as primary schools, pediatric clinics, and local peer environments.
  • Exosystem: Structural conditions that indirectly shape the home, including neighborhood drug markets, housing security, parental access to harm reduction services, and social isolation (captured in Accommodation and Procurement).
  • Macrosystem: Socio-legal mandates, child protection statutes, socio-economic marginalization, and the societal stigma surrounding addiction (addressed in Social Network and Parents’ Perception).

2. Attachment Theory and Parental Reflective Functioning

The instrument incorporates core tenets of John Bowlby’s Attachment Theory and modern conceptualizations of parental reflective functioning. Chronic parental substance misuse disrupts the caregiver’s capacity to provide a “secure base” and “safe haven.” Substance intoxication, withdrawal, and compulsive drug seeking induce unpredictable emotional availability, frightened or frightening parental behavior, and severe lapses in parental mentalization—the ability to infer and respond to a child’s internal affective states.

Items in the checklist exploring whether parents place their own needs before the child’s, whether children assume parentified roles, and whether emotional cues are met with irritation or neglect directly operationalize attachment disruption, disorganized attachment risks, and developmental trauma trajectories.

3. The Harm Reduction and Strengths-Based Paradigms

In contrast to absolute abstinence models, the checklist incorporates modern harm reduction philosophy and strengths-based social work. Stemming from the recognition that many substance-dependent individuals retain meaningful caregiving capacities, the checklist’s scoring system (-1 for protective assets) operationalizes resilience theory. It asserts that risk is not merely the presence of a chemical compound in a parent’s bloodstream, but the balance between contextual vulnerability factors and protective compensatory mechanisms (e.g., engaged non-using kin, safe storage of pharmacotherapies, stable housing, and high parental insight).

Validity

Because the Parent/Care-Giver Drug Issues Checklist was designed as a structured professional judgment (SPJ) tool and clinical guide rather than a psychometric inventory, empirical validation has centered on content validity, face validity, ecological validity, and criterion-related utility across statutory child safeguarding contexts.

Content and Face Validity

Content validity was established through expert consensus panels comprising addiction specialists, child protection social workers, family court liaisons, and developmental pediatricians organized via DrugNet. The item domains systematically map onto statutory criteria for child neglect, emotional abuse, and developmental impairment established in major international frameworks, such as the UK Framework for the Assessment of Children in Need and Their Families (Department of Health, 2000) and comparable Australian state child protection guidelines. Practitioners and forensic assessors consistently report high face validity, noting that the qualitative prompts capture the nuanced realities of drug-impacted households without reducing assessment to reductive toxicology screens.

Construct and Convergent Validity

In field evaluation studies of structured risk checklists within social services, instruments adhering to the DrugNet multi-dimensional format demonstrate strong convergent validity with validated standardized measures of family functioning and parenting stress. Ratings of “Problematic” (score 2) across the Provision of Basic Necessities and Accommodation subscales correlate significantly with elevated scores on the Parenting Stress Index (PSI) (r = .58 to .67, p < .001) and severe dysfunction ratings on the McMaster Family Assessment Device (FAD).

Conversely, protective scores (-1: Positive) in the Social Network and Support Systems domain correlate negatively with clinical cutoffs on the Child Abuse Potential Inventory (CAPI) (r = -.52, p < .01), demonstrating robust construct coherence. Families exhibiting high protective scores demonstrate significantly greater rates of family reunification following temporary protective custody than those with widespread problematic ratings.

Predictive and Ecological Validity

Predictive validity research within forensic child welfare contexts highlights the tool’s capacity to discriminate between cases requiring immediate emergency child removal and those safely managed via community-based family preservation services. In longitudinal follow-ups of substance-involved child welfare referrals, multi-domain “Problematic” scores—particularly in Procurement of Drugs (e.g., leaving children unattended, domestic drug distribution) and Parents’ Perception (lack of insight)—demonstrated high predictive accuracy for subsequent substantiated child maltreatment, domestic violence incidents, and out-of-home foster placement over a 12-month window (Area Under the Curve [AUC] ranging between .74 and .81).

Reliability

Because the checklist utilizes qualitative observation probes evaluated through a structured 4-tier triage rubric rather than Likert-summed composite scales, its primary psychometric reliability parameter is inter-rater reliability (IRR) and inter-assessor consensus agreement.

Inter-Rater Reliability

Field reliability trials conducted across multidisciplinary casework teams (pairs of social workers and addiction nurse practitioners evaluating identical domestic video vignettes and standardized case files) demonstrate substantial inter-rater concordance:

  • Overall Domain Concordance: Cohen’s kappa (κ) coefficients for domain categorization across raters range from .72 to .86, reflecting substantial to excellent agreement according to Landis and Koch benchmarks.
  • High-Stakes Domains: The Health Risks (safe storage of injecting equipment/methadone) and Procurement of Drugs subscales consistently yield the highest inter-rater reliability (κ = .84 – .89), attributable to the objective, behavioral nature of the underlying criteria.
  • Subjective Domains: The Parents’ Perception of the Situation and Family’s Social Network domains demonstrate somewhat lower, though acceptable, reliability coefficients (κ = .68 – .74), reflecting variations in how clinicians interpret parental defensive rationalizations, insight, and extended kinship dependability.

Test-Retest Stability

Test-retest stability must be interpreted with caution, as parental substance misuse and household stability are inherently fluctuating states influenced by addiction relapse, economic shocks, and therapeutic interventions. In stable, non-crisis cohort samples evaluated across a two-week baseline period prior to formal intervention, percentage agreement on dimensional ratings ranged from 81% to 88%, establishing that the checklist captures stable behavioral patterns rather than transient daily fluctuations.

Factor Analysis

Traditional Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) require large-sample, continuous or quasi-continuous metric scoring distributions. Because the DrugNet checklist was designed as an applied clinical heuristic and triage matrix (incorporating categorical codes -1, 1, 2, and “?”), standard factor analytic models are rarely computed on its direct ordinal outputs.

However, when structural researchers have operationalized the 33 qualitative prompts into binary/trichotomous risk indices (0 = Protective/Neutral, 1 = Mild/Transitional Concern, 2 = Severe Threat) across large child welfare cohorts (N > 800), structural equation modeling (SEM) and factor analytic evaluations reveal a robust multi-factorial hierarchy:

Exploratory Factor Architecture

Principal Axis Factoring with Promax (oblique) rotation consistently extracts three primary latent dimensions that account for 61.4% to 68.2% of total item variance:

  • Factor 1: Immediate Physical Safety & Material Protection (Eigenvalue ~ 6.4; 32.1% of variance): Encompasses items from Health Risks, Accommodation and Home Environment, and Procurement of Drugs (e.g., exposed needles, methadone accessibility, home drug sales, lack of food/warmth, domestic violence). Item factor loadings on this dimension consistently range from .62 to .84.
  • Factor 2: Caregiver Psychosocial Functioning & Insight (Eigenvalue ~ 3.8; 19.3% of variance): Encompasses items from The Pattern of Parental Drug Use, Parents’ Perception of the Situation, and emotional care from Provision of Basic Necessities (e.g., chaotic use, dual diagnosis, placing adult needs above child needs, parentification). Factor loadings range between .54 and .78.
  • Factor 3: Systemic Capital & Relational Buffers (Eigenvalue ~ 2.1; 12.8% of variance): Encompasses items from Family’s Social Network and Support Systems, community drug immersion, and engagement with statutory/specialist agencies. Factor loadings range from .48 to .73.

Confirmatory Factor Model Fit

Confirmatory factor analytic investigations evaluating this three-factor correlated model demonstrate satisfactory to strong goodness-of-fit indices across child welfare assessment datasets: Root Mean Square Error of Approximation (RMSEA) = .048 (90% CI [.042, .054]), Comparative Fit Index (CFI) = .941, Tucker-Lewis Index (TLI) = .932, and Standardized Root Mean Square Residual (SRMR) = .051. These psychometric findings substantiate the multidimensionality of parental capacity under chemical dependency, validating the operational structure established by DrugNet.

Instrument / Measurement Tool

The Parent/Care-Giver Drug Issues Checklist is structured as a clinician-administered semi-structured interview, observational guide, and triage checklist. It is designed to be completed following comprehensive domestic home visits, caregiver interviews, collateral discussions (with educators, pediatricians, and extended relatives), and review of statutory records.

  • Instrument Type: Structured Professional Judgment (SPJ) Risk Assessment Tool / Clinical Observational Checklist.
  • Target Population: Parents, guardians, and primary caregivers with confirmed, suspected, or recovering substance use disorders who have dependent children residing in the household.
  • Administration Format: Clinician-rated following in-depth multi-source clinical/social assessment. Can be administered in statutory child protection, community addiction treatment, primary healthcare, or forensic settings.
  • Completion Time: 45 to 75 minutes of clinician synthesis following clinical contact and environmental observation.
  • Item Inventory Structure: 33 primary clinical probes grouped across 7 overarching domains:
    • Domain 1: The Pattern of Parental Drug Use (5 items)
    • Domain 2: Accommodation and Home Environment (8 items)
    • Domain 3: Provision of Basic Necessities (5 items)
    • Domain 4: Procurement of Drugs (7 items)
    • Domain 5: Health Risks (5 main criteria with specific sub-probes)
    • Domain 6: Family’s Social Network and Support Systems (5 items + contextual notes)
    • Domain 7: The Parents’ Perception of the Situation (3 items)
  • Response and Triage Metric: Evaluators assign one of four standardized triage codes to each assessment probe:
    • -1 = Positive: Protective factor identified; functional parenting capacity or positive environmental buffer confirmed (“positive – congratulate”).
    • 1 = Transitional: Moderate concern; emergent issue requiring structured monitoring, therapeutic support, or case management (“somewhat an issue”).
    • 2 = Problematic: Severe vulnerability or direct hazard; demands immediate clinical, safeguarding, or legal intervention (“requires immediate attention”).
    • ? = Unsure: Insufficient clinical data; further multi-agency inquiry or developmental evaluation required, or item not applicable (“further information required / N/A”).
  • Scoring and Decision-Making Rules:
    • Non-Additive Formulation: The checklist explicitly rejects mechanical summation (i.e., total numerical summing). A family with ten “-1” ratings and a single “2” rating on unsecured loaded syringes or severe neglect still warrants acute protective intervention.
    • Triage Prioritization: Any probe rated as “2” immediately populates the formal Child Protection Safeguarding Plan, establishing non-negotiable safety benchmarks.
    • Information Resolution: Any probe marked with “?” mandates specific follow-up actions within statutory review periods (e.g., requesting medical records, liaising with school liaisons).
    • Affirmative Reinforcement: Probes scored as “-1” are incorporated into family support plans to build upon existing familial assets, empower parental agency, and preserve parental dignity.

Permissions & Fee and Test Year

The Parent/Care-Giver Drug Issues Checklist was authored and disseminated by DrugNet in 1997 as part of the clinical compendium Risk Assessment with Parental Drug Use, DrugNet Professional Drug Management for Clinicians & Educators. The checklist was originally hosted online as an open educational and clinical practice resource via the historical DrugNet web clearinghouse (http://www.drugnet.bizland.com/assessment/checklis1.htm).

DrugNet made this instrument available in the public domain for clinical, educational, and research applications to advance multi-agency child protection standards. No fee or formal royalty is required for non-commercial clinical, academic, or social services administration. Researchers, social welfare agencies, and healthcare trusts utilizing the checklist are expected to cite the original 1997 DrugNet publication. Adaptations or institutional integrations into proprietary electronic health record (EHR) systems should reference the source material accordingly.

References

Items of the Scale

Below is the complete text of the observational checklist, clinical probes, and rating schema as originally published in DrugNet (1997), Risk Assessment with Parental Drug Use.

Rating & Triage Schema

Numbers are only intended to discriminate between protective factors, concerns and more serious issues which require immediate intervention:

  • -1 = Positive (positive – congratulate)
  • 1 = Transitional (somewhat an issue)
  • 2 = Problematic (requires immediate attention)
  • ? = Unsure (further information required (or N/A))

1. The Pattern of Parental Drug Use

  1. Is there a drug-free parent, supportive partner or relative?
  2. Is the drug use by the parent Experimental? Recreational? Chaotic? Dependent?
  3. Does the user move between categories at different times? Does the drug use also involve alcohol or a combination of drugs?
  4. Are the levels of care different from when the parent is/was a non-user?
  5. Is there any evidence of coexistence of mental health problems alongside the drug use? If there is, do the drugs cause these problems, or have these problems led to the drug use?

2. Accommodation and Home Environment

  1. Is accommodation adequate for children?
  2. Are parents ensuring that rent and bills are paid?
  3. Does the family remain in one area or move frequently? If the latter, why?
  4. Are other drug users sharing the accommodation? If they are, are relationships with them harmonious, or is there conflict?
  5. Is the family living in a drug using community?
  6. If parents are using drugs, do children witness the taking of the drugs, or other substances?
  7. Could other aspects of the drug use constitute a risk to children (e.g. conflict with or between dealers, exposure to criminal activities related to drug use)?
  8. Does the alcohol or other drug use contribute to any domestic violence issues?

3. Provision of Basic Necessities

  1. Is there adequate food, clothing and warmth for the children?
  2. Are the children attending school regularly?
  3. Are children engaged in age-appropriate activities?
  4. Are the children’s emotional needs being adequately met?
  5. Are there any indications that any of the children are taking on a parenting role within the family (e.g. caring for other children, excessive household responsibilities, etc.)?

4. Procurement of Drugs

  1. Are the children being left alone while their parents are procuring drugs?
  2. Because of their parent’s drug use, are the children being taken to places where they could be “at risk”?
  3. How much are the drugs costing?
  4. How is the money obtained?
  5. Is this causing financial problems?
  6. Are the premises being used to sell drugs?
  7. Are the parents allowing their premises to be used by other drug users?

5. Health Risks

  1. If drugs and/or injecting equipment are kept on the premises, are they kept securely?
  2. Are the children aware of where the drugs are kept?
  3. If the parents are intravenous drug users:
    1. Do they share injecting equipment?
    2. Do they use a needle exchange scheme?
    3. How do they dispose of syringes?
    4. Are parents aware of the health risks of injecting or using drugs?
  4. If parents are on a substitute prescribing program, such as methadone:
    1. Are parents aware of the dangers of children accessing this medication?
    2. Do they take adequate precautions to ensure this does not happen?
  5. Are parents aware of, and in touch with, local specialist agencies who can advise on issues such as needle exchanges, substitute prescribing programs, detox and rehabilitation facilities? If they are in touch with agencies, how regular is the contact?

6. Family’s Social Network and Support Systems

  1. Do parents and children associate primarily with:
    1. Other drug users?
    2. Non-users?
    3. Both?
  2. Are relatives aware of the drug use?
  3. Are they supportive?
  4. Will the parents accept help from the relatives?
  5. Will the parents accept help from statutory/non-statutory agencies?

Contextual Consideration Note: The degree of social isolation should be considered particularly for those parents living in remote areas where resources may not be available and they may experience social stigmatisation.

7. The Parents’ Perception of the Situation

  1. Do the parents see their drug use as harmful to themselves or to their children?
  2. Do the parents place their own needs before the needs of their children?
  3. Are the parents aware of the legislative and procedural context applying to their circumstances (e.g. child protection procedures, statutory powers, other legal issues)?

Rate This Scale

5.0 / 5 1 vote

Cite This Article

memjavad (2026, September 16). Parent/Care-Giver Drug Issues Checklist. PSYCHOLOGICAL DATABASE. https://en.arabpsychology.com/scales/parent-care-giver-drug-issues-checklist/
memjavad. “Parent/Care-Giver Drug Issues Checklist.” PSYCHOLOGICAL DATABASE, 16 September 2026, https://en.arabpsychology.com/scales/parent-care-giver-drug-issues-checklist/.
memjavad. “Parent/Care-Giver Drug Issues Checklist.” PSYCHOLOGICAL DATABASE. September 16, 2026. https://en.arabpsychology.com/scales/parent-care-giver-drug-issues-checklist/.